![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.fiercepharma.com/pharma/appeals-court-shoots-down-ucbs-neupro-patch-patent-allowing-actavis-and-mylan-generics
https://www.accesswire.com/720788/XPhyto-Reports-Excellent-Rotigotine-In-VitroEx-Vivo-Results-for-Parkinsons-Disease-Treatment
https://www.accesswire.com/700572/XPhyto-Reports-Product-Developments-on-Platform-Based-Rotigotine-Transdermal-Patch-for-Parkinsons-Disease
https://www.accesswire.com/695803/XPhyto-Reports-Market-and-Product-Developments-on-Platform-based-Rotigotine-Transdermal-Patch-for-Parkinsons-Disease
https://www.accesswire.com/667674/XPhyto-Reports-Development-Update-for-its-Drug-Delivery-Business
https://www.gov.uk/drug-safety-update/letters-and-drug-alerts-sent-to-healthcare-professionals-in-july-2019
https://www.fiercepharma.com/pharma/public-citizen-says-enough-enough-dopamine-agonist-petition-files-for-injunction
http://www.fiercepharmaasia.com/story/china-fda-ahead-ucbs-neupro-after-phiii-parkinsons-results/2015-06-18